Senate Republicans on the Finance Committee are currently deliberating on the nomination of Robert F. Kennedy Jr. for a key position. As of Tuesday morning, it remains uncertain whether Kennedy has garnered enough votes to pass out of the panel.
One GOP member, Sen. Bill Cassidy, declined to disclose his stance on Kennedy's nomination, keeping his vote undisclosed. When questioned about the review process, Cassidy, a medical professional facing reelection in 2026, responded with a jovial laugh.
Similarly, Sen. John Cornyn refrained from speculating on the outcome of Kennedy's nomination within the committee. Cornyn emphasized the need to wait for the voting results before drawing any conclusions.
Addressing concerns about Kennedy's views on vaccines, Cornyn stated that Kennedy had assured him of his pro-safety stance rather than being anti-vaccine. Cornyn drew an analogy to Kennedy's perspective on vaccines by likening it to removing mercury from fish not implying an anti-fish sentiment.
Senate Finance Chair Mike Crapo also refrained from predicting the voting outcome for Kennedy's nomination. Crapo had previously stated that he would not preemptively determine the result of the nomination process.
The deliberations surrounding Robert F. Kennedy Jr.'s nomination continue within the Senate Finance Committee, with members maintaining a cautious approach until the votes are cast and the decision is made.
